Roles of exogenously regulated bFGF expression in angiogenesis and bone regeneration in rat calvarial defects

International Journal of Molecular Medicine

Volumn 27, Issue 4, 2011, Pages 545-553

  Chen, Meiling ^a   Song, Ke ^a   Rao, Nianjing ^a   Huang, Mengqi ^a   Huang, Zhengjiang ^a   Cao, Yingguang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Bone regeneration; Gene regulation system; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BASIC FIBROBLAST GROWTH FACTOR; DOXYCYCLINE; MESSENGER RNA; TETRACYCLINE; TRANSCRIPTION FACTOR RUNX2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REGENERATION; CALVARIAL DEFECT; CELL DIFFERENTIATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE REMODELING; CALCIUM PHOSPHATES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEPENDOVIRUS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE THERAPY; GENETIC VECTORS; MALE; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SKULL;

EID: 79952210988     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.619     Document Type: Article

References (32)

1. Kneser U, Schaefer DJ, Polykandriotis E and Horch RE: Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10: 7-19, 2006. (Pubitemid 44882940)
2. Goiato MC, Anchieta RB, Pita MS and dos Santos DM: Reconstruction of skull defects: currently available materials. J Craniofac Surg 20: 1512-1518, 2009.
3. Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W and Schieker M: Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 39 (Suppl. 2): S9-S20, 2008.
4. Betz VM, Betz OB, Harris MB, Vrahas MS and Evans CH: Bone tissue engineering and repair by gene therapy. Front Biosci 13: 833-841, 2008. (Pubitemid 351606118)
5. Hao J, Varshney RR and Wang DA: Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells. Curr Opin Mol Ther 11: 404-410, 2009.
6. Zellin G: Growth factors and bone regeneration. Implications of barrier membranes. Swed Dent J (Suppl) 129: 7-65, 1998.
7. Radomsky ML, Thompson AY, Spiro RC and Poser JW: Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res 355 (Suppl.): S283-293, 1998.
8. Nomi M, Miyake H, Sugita Y, Fujisawa M and Soker S: Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther 1: 333-343, 2006.
9. Kim MS, Bhang SH, Yang HS, et al: Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis. Tissue Eng (Part A) 16: 2999-3010, 2010.
10. Kanczler JM and Oreffo RO: Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114, 2008. (Pubitemid 351955734)
11. Gafni Y, Pelled G, Zilberman Y, et al: Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9: 587-595, 2004. (Pubitemid 38578809)
12. Li Q, Dai J and Rabie AB: Recombinant adeno-associated virus serotype 2 (rAAV2)-An efficient vector for gene delivery in condylar cartilage, glenoid fossa and TMJ disc in an experimental study in vivo. Arch Oral Biol 54: 943-950, 2009.
13. Gossen M and Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551, 1992.
14. Han Y, Chang QA, Virag T, West NC, George D, Castro MG and Bohn MC: Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors. Gene Ther 17: 616-625, 2010.
15. Bianco P, Riminucci M, Gronthos S and Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192, 2001. (Pubitemid 32524539)
16. Hutmacher DW and Cool S: Concepts of scaffold-based tissue engineering - the rationale to use solid free-form fabrication techniques. J Cell Mol Med 11: 654-669, 2007. (Pubitemid 47315712)
17. Ponnazhagan S, Yoder MC and Srivastava A: Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 71: 3098-3104, 1997. (Pubitemid 27119956)
18. Franceschi RT: Biological approaches to bone regeneration by gene therapy. J Dent Res 84: 1093-1103, 2005.
19. Pri-Chen S, Pitaru S, Lokiec F and Savion N: Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23: 111-117, 1998. (Pubitemid 28379871)
20. Naganawa T, Xiao L, Coffin JD, Doetschman T, Sabbieti MG, Agas D and Hurley MM: Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 103: 1975-1988, 2008.
21. Moutsatsos IK, Turgeman G, Zhou S, et al: Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3: 449-461, 2001. (Pubitemid 32509838)
22. Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, Gold LI and Longaker MT: Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms. Plast Reconstr Surg 106: 360-372, 2000.
23. Yu P, Passam FH, Yu DM, Denyer G and Krilis SA: Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost 6: 1215-1223, 2008. (Pubitemid 351859131)
24. Cohen MM Jr: The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A 140: 2646-2706, 2006.
25. Leach JK, Kaigler D, Wang Z, Krebsbach PH and Mooney DJ: Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27: 3249-3255, 2006. (Pubitemid 43344337)
26. Ishida K, Matsumoto T, Sasaki K, et al: Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A 16: 3271-3284, 2010.
27. Harris WH: A microscopic method of determining rates of bone growth. Nature 188: 1038-1039, 1960.
28. Suzuki HK, Mathews A: Two-color fluorescence labeling of mineralizing tissues with tetracycline and 2,4-bis [N,N′-di(carbomethyl)aminomethyl] fluorescein. Stain Technol 41: 57-60, 1966.
29. Lee TC, Arthur TL, Gibson LJ and Hayes WC: Sequential labelling of microdamage in bone using chelating agents. J Orthop Res 18: 322-325, 2000. (Pubitemid 30304763)
30. Wu Y, Chen L, Scott PG and Tredget EE: Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659, 2007. (Pubitemid 47582758)
31. Zerbo IR, Bronckers AL, de Lange G and Burger EH: Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 26: 1445-1451, 2005. (Pubitemid 39336522)
32. Artzi Z, Weinreb M, Givol N, Rohrer MD, Nemcovsky CE, Prasad HS and Tal H: Biomaterial resorption rate and healing site morphology of inorganic bovine bone and beta-tricalcium phosphate in the canine: a 24-month longitudinal histologic study and morphometric analysis. Int J Oral Maxillofac Implants 19: 357-368, 2004. (Pubitemid 38822323)